P0935 Unlocking senolytic-immunotherapy in bladder cancer: A multi-omics roadmap from senescence subtyping to combination therapy

European Urology 2026

View at publisher

Authors: T. Liu, J. Yao, C. Wang, C. Wang

DOI: 10.1016/s0302-2838(26)01790-2

Cited by: 0

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments Telomeres Telomerase and Senescence Cancer Immunotherapy and Biomarkers